The drug is indicated for prevention and control of postpartum haemorrhage
Lupin launched Methylergonovine Maleate tablets, used for prevention and control of postpartum haemorrhage, in the American market. The company has launched the product in the US after having received approval from the US Food and Drug Administration (US FDA) earlier, Lupin said in a statement.
Lupin’s product is the generic equivalent of Novartis Pharmaceuticals Corp’s Methergine which is indicated for prevention and control of postpartum haemorrhage. As per the latest industry estimates, Methylergonovine Maleate tablets had annual sales of around $ 71.5 million.
Comments are closed.